Kelli Oswald

1.8k total citations
9 papers, 632 citations indexed

About

Kelli Oswald is a scholar working on Infectious Diseases, Molecular Biology and Virology. According to data from OpenAlex, Kelli Oswald has authored 9 papers receiving a total of 632 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 4 papers in Molecular Biology and 4 papers in Virology. Recurrent topics in Kelli Oswald's work include HIV Research and Treatment (4 papers), HIV/AIDS drug development and treatment (3 papers) and Herpesvirus Infections and Treatments (2 papers). Kelli Oswald is often cited by papers focused on HIV Research and Treatment (4 papers), HIV/AIDS drug development and treatment (3 papers) and Herpesvirus Infections and Treatments (2 papers). Kelli Oswald collaborates with scholars based in United States. Kelli Oswald's co-authors include Kevin Camphausen, William Burgan, Philip J. Tofilon, Michael Cerra, Jeffery S. Russell, Jane B. Trepel, Min-Jung Lee, Melinda G. Hollingshead, Hideaki Dote and Jeffrey D. Lifson and has published in prestigious journals such as Cancer Research, Journal of Virology and Clinical Cancer Research.

In The Last Decade

Kelli Oswald

8 papers receiving 616 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kelli Oswald United States	7	437	127	104	81	74	9	632
Sherly Mosessian United States	8	423 1.0×	144 1.1×	68 0.7×	49 0.6×	38 0.5×	12	627
Marion Larroque France	11	483 1.1×	152 1.2×	124 1.2×	62 0.8×	34 0.5×	21	835
Louise Boyer-Châtenet France	9	483 1.1×	211 1.7×	54 0.5×	51 0.6×	40 0.5×	12	685
Yanping Wang China	16	328 0.8×	123 1.0×	79 0.8×	47 0.6×	84 1.1×	32	656
Kris Barreto Canada	16	329 0.8×	118 0.9×	112 1.1×	83 1.0×	249 3.4×	32	611
Marisa M. Juntilla United States	9	361 0.8×	130 1.0×	162 1.6×	153 1.9×	32 0.4×	12	822
Tatenda Mahlokozera United States	10	138 0.3×	75 0.6×	65 0.6×	52 0.6×	20 0.3×	15	421
M Guigon France	20	351 0.8×	232 1.8×	118 1.1×	96 1.2×	63 0.9×	48	994
Shitao Zou China	16	437 1.0×	148 1.2×	61 0.6×	40 0.5×	30 0.4×	38	649
Boris Brill Germany	15	266 0.6×	183 1.4×	50 0.5×	15 0.2×	50 0.7×	33	578

Countries citing papers authored by Kelli Oswald

Since Specialization

Citations

This map shows the geographic impact of Kelli Oswald's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelli Oswald with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelli Oswald more than expected).

Fields of papers citing papers by Kelli Oswald

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kelli Oswald. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelli Oswald. The network helps show where Kelli Oswald may publish in the future.

Co-authorship network of co-authors of Kelli Oswald

This figure shows the co-authorship network connecting the top 25 collaborators of Kelli Oswald. A scholar is included among the top collaborators of Kelli Oswald based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelli Oswald. Kelli Oswald is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Parren, Mara, Raiza Bastidas, Joseph G. Jardine, et al.. (2025). Combining a rhesus cytomegalovirus/SIV vaccine with a neutralizing antibody to protect against SIV challenges in rhesus macaques. Frontiers in Microbiology. 16. 1592647–1592647.

Swanstrom, Adrienne E., Robert J. Gorelick, Guoxin Wu, et al.. (2018). Ultrasensitive Immunoassay for Simian Immunodeficiency Virus p27 ^CA. AIDS Research and Human Retroviruses. 34(11). 993–1001. 6 indexed citations

Fennessey, Christine M., Mykola Pinkevych, Taina T. Immonen, et al.. (2017). Genetically-barcoded SIV facilitates enumeration of rebound variants and estimation of reactivation rates in nonhuman primates following interruption of suppressive antiretroviral therapy. PLoS Pathogens. 13(5). e1006359–e1006359. 66 indexed citations

Jensen, Kara, Michael Piatak, Rebecca Shoemaker, et al.. (2016). Balancing Trained Immunity with Persistent Immune Activation and the Risk of Simian Immunodeficiency Virus Infection in Infant Macaques Vaccinated with Attenuated Mycobacterium tuberculosis or Mycobacterium bovis BCG Vaccine. Clinical and Vaccine Immunology. 24(1). 34 indexed citations

Prete, Gregory Q. Del, Haesun Park, Christine M. Fennessey, et al.. (2014). Molecularly Tagged Simian Immunodeficiency Virus SIVmac239 Synthetic Swarm for Tracking Independent Infection Events. Journal of Virology. 88(14). 8077–8090. 31 indexed citations

Dote, Hideaki, William Burgan, Michael Cerra, et al.. (2004). Enhanced Tumor Cell Radiosensitivity and Abrogation of G2 and S Phase Arrest by the Hsp90 Inhibitor 17-(Dimethylaminoethylamino)-17-demethoxygeldanamycin. Clinical Cancer Research. 10(23). 8077–8084. 81 indexed citations

Camphausen, Kevin, William Burgan, Michael Cerra, et al.. (2004). Enhanced Radiation-Induced Cell Killing and Prolongation of γH2AX Foci Expression by the Histone Deacetylase Inhibitor MS-275. Cancer Research. 64(1). 316–321. 183 indexed citations

Russell, Jeffery S., William Burgan, Kelli Oswald, Kevin Camphausen, & Philip J. Tofilon. (2003). Enhanced cell killing induced by the combination of radiation and the heat shock protein 90 inhibitor 17-allylamino-17- demethoxygeldanamycin: a multitarget approach to radiosensitization.. PubMed. 9(10 Pt 1). 3749–55. 94 indexed citations

Russell, Jeffery S., William Burgan, Michael Cerra, et al.. (2003). Gleevec-mediated inhibition of Rad51 expression and enhancement of tumor cell radiosensitivity.. PubMed. 63(21). 7377–83. 137 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact